ACTA MEDICA MEDITERRANEA, cilt.33, sa.4, ss.549-555, 2017 (SCI-Expanded)
Background: The role of molecular markers in ovarian cancer is still a matter of debate. This study was conducted to determine the clinical significance of serum Omentin-1 in epithelial ovarian cancer (EOC) patients in the current matched case-control study.